-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Initiates Coverage On PROCEPT BioRobotics with Neutral Rating, Announces Price Target of $30

Benzinga·03/06/2026 10:39:33
Listen to the news
Baird analyst David Rescott initiates coverage on PROCEPT BioRobotics (NASDAQ:PRCT) with a Neutral rating and announces Price Target of $30.